SI-722
- Generic Name
- SI-722
PK and Safety of SI-722 in IC/BPS
Phase 1
Completed
- Conditions
- Interstitial CystitisBladder Pain Syndrome
- Interventions
- Drug: Placebo
- First Posted Date
- 2019-12-23
- Last Posted Date
- 2023-12-29
- Lead Sponsor
- Seikagaku Corporation
- Target Recruit Count
- 33
- Registration Number
- NCT04208087
- Locations
- 🇺🇸
TriValley Urology Medical Group, Murrieta, California, United States
🇺🇸Premier Medical Associates, The Villages, Florida, United States
🇺🇸American Institute of Research, Los Angeles, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath